96 - The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas. - Tarantelli, C.; Gaudio, E.; Hillmann, P.; Spriano, F.; Rinaldi, A.; Kwee, I.; Cascione, L.; Fabbro, D.; Stathis, A.; Zucca, E.; Cmiljanovic, V.; Bertoni, F. (European Journal of Cancer, 2016)